COMMUNIQUÉS West-GlobeNewswire

Inotiv, Inc. to Participate in Three Investor Conferences in November 2025
21/10/2025
WEST LAFAYETTE, Ind., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Inotiv, Inc. (NASDAQ: NOTV) (the “Company”, or “Inotiv”), a leading contract research organization specializing in nonclinical and analytical drug discovery and [...]
Eagle Pharmaceuticals Announces Results of 2025 Annual Meeting of Stockholders
21/10/2025
WOODCLIFF LAKE, N.J., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Eagle Pharmaceuticals, Inc. (OTCMKTS: EGRX) (the “Company” or “Eagle”) is pleased to announce the voting results for each of the matters presented at the Company’s [...]
InspireMD to Announce Third Quarter 2025 Financial Results
21/10/2025
MIAMI, Oct. 21, 2025 (GLOBE NEWSWIRE) -- InspireMD, Inc. (Nasdaq: NSPR), developer of the CGuard® Prime carotid stent system for the prevention of stroke, today announced that it will release its third quarter 2025 [...]
Madrigal Pharmaceuticals Announces Grants of Inducement Awards under Nasdaq Listing Rule 5635(c)(4)
21/10/2025
CONSHOHOCKEN, Pa., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL), a biopharmaceutical company focused on delivering novel therapeutics for metabolic dysfunction-associated [...]
NurExone Invited Presenter at Precision EV Forum in Cambridge, UK
21/10/2025
Highlighting Regulatory and Clinical Leadership in Regenerative Exosome Therapies TORONTO and HAIFA, Israel, Oct. 21, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or [...]
RAPT Therapeutics Announces Proposed Public Offering of Common Stock
21/10/2025
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- RAPT Therapeutics, Inc. (Nasdaq: RAPT) (“RAPT”), a clinical-stage immunology-based biopharmaceutical company focused on discovering, developing and [...]
Rhythm Pharmaceuticals to Report Third Quarter 2025 Financial Results on Tuesday, November 4, 2025
21/10/2025
BOSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Rhythm Pharmaceuticals, Inc. (Nasdaq: RYTM), a global commercial-stage biopharmaceutical company focused on transforming the lives of patients living with rare neuroendocrine [...]
Fairhaven Health Highlights Science-Driven Solutions for Women During Menopause Awareness Month
21/10/2025
MIDDLETOWN, Conn., Oct. 21, 2025 (GLOBE NEWSWIRE) -- October marks Menopause Awareness Month, a time to focus on the physical and emotional changes that affect more than 1 million American women each year. Fairhaven [...]
Quercis Pharma and The Galien Foundation to Spotlight Sickle Cell Disease at the 2025 Patient Summit
21/10/2025
NEW YORK, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Quercis Pharma is proud to sponsor Panel 6 — “The Forgotten Patients: A Focus on Sickle Cell Disease” at The Galien Foundation’s 2025 Patient Summit, taking place on Thursday [...]
beyond|AESTHETICS Owner Leslie Petersen, NP, Accepted into Elite Dr. Mauricio de Maio MD Codes™ Fellowship Program
21/10/2025
Camarillo, CA, Oct. 21, 2025 (GLOBE NEWSWIRE) -- beyond|AESTHETICS is proud to announce that its owner, Leslie Petersen, NP , has been selected as one of only 15 individuals nationally for the highly coveted Dr. [...]
Glo & Spa-rkle Aesthetics and Medspa Celebrates 700-Plus 5-Star Google Reviews, Cementing Rank as Best Laser Tattoo Removal Medspa in Lubbock, Texas.
21/10/2025
Glo & Spa-rkle Aesthetics and Medical Spa achieves a significant milestone, reinforcing its commitment to excellence in aesthetic and wellness services. Lubbock, TX, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Glo & Spa- [...]
Cosmos Health Expands Its Ethereum Holdings With an Additional $200,000 Purchase Under Its $300 Million Digital Assets Facility; Total Investment Now Reaches $2 Million
21/10/2025
CHICAGO, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced that it has acquired an [...]
IPSEN - Buy-back programme - Art 5 of MAR - Week 42 - 2025
21/10/2025
Aggregated presentation by day and by market Statement of transactions in own shares from October 13th to October 17th 2025 Name of the issue Identity code of the issuer (Legal Entity Identifier) Day of the transaction [...]
IPSEN - Achats effectués dans les conditions de l'Article 5 du Règlement MAR - Semaine 42 - 2025
21/10/2025
Présentation agrégée par jour et par marché Déclaration des transactions sur actions propres réalisées du 13 Octobre au 17 Octobre 2025 Nom de l'émetteur Code identifiant de l'émetteur (code LEI) Jour de la transaction [...]
Curia Sterile Drug Product Facility Named Massachusetts Manufacturer of the Year
21/10/2025
ALBANY, N.Y., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Curia Global, Inc. (Curia), a leading contract research, development and manufacturing organization, today announced its Burlington, MA sterile drug product facility has [...]
Raw Garden Acquires “California Love” to Grow Their Clean Cannabis Movement
21/10/2025
Acquisition strengthens Raw Garden’s mission to expand access to clean cannabis across California SANTA BARBARA, Calif., Oct. 21, 2025 (GLOBE NEWSWIRE) -- Raw Garden, California’s leader in clean cannabis for over a [...]
Alignment Health Plan Joins Forces with Suvida Healthcare to Expand Bilingual Care, Access for Arizona Seniors
21/10/2025
New agreement brings culturally attuned, neighborhood-based care to 1+ million Medicare-eligible adults in Maricopa and Pima counties PHOENIX, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Alignment Health Plan , an award-winning [...]
KFSHRC réalise la première résection robotisée au monde d’une tumeur intracrânienne... Une nouvelle ère en neurochirurgie
21/10/2025
RIYAD, Arabie saoudite, 21 oct. 2025 (GLOBE NEWSWIRE) -- Dans une avancée historique pour la robotique médicale, le King Faisal Specialist Hospital and Research Centre (KFSHRC) de Riyad a réalisé avec succès la première [...]
Step Pharma to spotlight work in CTPS2-null solid tumours at 2025 EORTC-NCI-AACR International Conference on Molecular Targets and Cancer Therapeutics
21/10/2025
Saint-Genis-Pouilly, France, 21 October 2025 – Step Pharma (“the Company”), the global leader in CTPS1 inhibition for targeted cancer treatment, today announces that its Chief Scientific Officer, Philip Beer, will be [...]

Pages